The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study

  • Lee, Seong Jun (Division of Hematology-Oncology, Department of Internal Medicine, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Suh, Cheol Won (Department of Internal Medicine, Asan Medical Center) ;
  • Lee, Soon Il (Department of Internal Medicine, Dankook University Hospital) ;
  • Kim, Won Seog (Department of Internal Medicine, Samsung Medical Center) ;
  • Lee, Won Sik (Department of Internal Medicine, Inje University Busan Paik Hospital) ;
  • Kim, Hyo Jung (Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Choi, Chul Won (Department of Internal Medicine, Korea University Guro Hospital) ;
  • Kim, Jin Seok (Department of Internal Medicine, Severance Hospital) ;
  • Shin, Ho-Jin (Division of Hematology-Oncology, Department of Internal Medicine, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • The Consortium for Improving Survival of Lymphoma (The Consortium for Improving Survival of Lymphoma)
  • Received : 2013.06.09
  • Accepted : 2013.10.04
  • Published : 2014.05.01
⟨ Previous Next ⟩

Abstract

Background/Aims: In Asia, the incidence of non-Hodgkin lymphoma (NHL) has increased in recent decades. Waldeyer's ring (WR) is the most common site of NHL involving the head and neck. In this study, the pathological distribution of WR-NHL and its clinical features were analyzed retrospectively. Methods: From January 2000 through December 2010, we analyzed the medical records of 328 patients from nine Korean institutions who were diagnosed with WR-NHL. Results: The study group comprised 197 male and 131 female patients with a median age of 58 years (range, 14 to 89). The rate of localized disease (stage I/II) was 64.9%, and that of low-risk disease (low/low-intermediate, as defined by the International Prognostic Index) was 76.8%. Diffuse large B-cell lymphoma (DLBCL; 240 patients, 73.2%) was the most common pathologic subtype, followed by peripheral T-cell lymphoma (14 patients, 4.3%) and nasal NK/T-cell lymphoma (14 patients, 4.3%). WR-NHL occurred most frequently in the tonsils (199 patients, 60.6%). Extranodal involvement was greater with the T-cell subtype (20 patients, 42.5%) compared with the B-cell subtype (69 patients, 24.5%). Multivariate analyses showed that age ${\geq}62$ years, T-cell subtype, and failure to achieve complete remission were significant risk factors for overall survival. Conclusions: DLBCL was found to have a higher incidence in Korea than those incidences reported by other WR-NHL studies. T-cell lymphoma occurred more frequently than did follicular lymphoma. T-cell subtype, age ${\geq}62$ years, and complete remission failure after first-line treatment were significant poor prognostic factors for overall survival according to the multivariate analysis.

Keywords

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917. https://doi.org/10.1002/ijc.25516
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. https://doi.org/10.3322/canjclin.55.2.74
  3. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol 2000;12:383-394. https://doi.org/10.1097/00001622-200009000-00002
  4. Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 1994;5 Suppl 1:19-24. https://doi.org/10.1093/annonc/5.suppl_5.19
  5. Hoppe RT, Burke JS, Glatstein E, Kaplan HS. Non-Hodgkin's lymphoma: involvement of Waldeyer's ring. Cancer 1978;42:1096-1104. https://doi.org/10.1002/1097-0142(197809)42:3<1096::AID-CNCR2820420310>3.0.CO;2-Z
  6. Yuen A, Jacobs C. Lymphomas of the head and neck. Semin Oncol 1999;26:338-345.
  7. Yong W, Zhang Y, Zheng W, Wei Y. Prognostic factors and therapeutic efficacy of combined radio-chemotherapy in Waldeyer's ring non-Hodgkin lymphoma. Chin Med J (Engl) 2000;113:148-150.
  8. Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg 1986;112:654-658. https://doi.org/10.1001/archotol.1986.03780060066010
  9. Ko YH, Lee JD, Kim CM, Kim IS, Lee MJ. Malignant lymphomas of the nasal cavity and Waldeyer's ring: clinicopathologic and immunohistochemical study. J Korean Med Sci 1992;7:314-324. https://doi.org/10.3346/jkms.1992.7.4.314
  10. Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity: clinical and immunologic aspects. Cancer 1985;56:768-776. https://doi.org/10.1002/1097-0142(19850815)56:4<768::AID-CNCR2820560412>3.0.CO;2-W
  11. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classif ication: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: International Agency for Research on Cancer, 2008.
  12. Jaffe ES, Harris NL, Stein H, et al., eds. WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon: International Agency for Research on Cancer, 2001.
  13. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007;67:5042-5054. https://doi.org/10.1158/0008-5472.CAN-06-4752
  14. Ryu MH, Kim BS, Kim TW, et al. Subclassif ication of diffuse large B-cell lymphomas according to the real classification: distinction of immunoblastic and non-immunoblastic subtypes. Korean J Med 2003;65:71-80.
  15. Krol AD, Le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noorduk EM. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry. Leuk Lymphoma 2001;42:1005-1013. https://doi.org/10.3109/10428190109097720
  16. Kwong YL, Anderson BO, Advani R, et al. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009;10:1093-1101. https://doi.org/10.1016/S1470-2045(09)70265-7
  17. Harabuchi Y, Tsubota H, Ohguro S, et al. Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring. Acta Oncol 1997;36:413-420. https://doi.org/10.3109/02841869709001289
  18. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004;28:1401-1416. https://doi.org/10.1097/01.pas.0000138177.10829.5c
  19. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 2003;22:5131-5140. https://doi.org/10.1038/sj.onc.1206551
  20. Engels EA, Cerhan JR, Linet MS, et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005;162:1153-1161. https://doi.org/10.1093/aje/kwi341
  21. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994. https://doi.org/10.1056/NEJM199309303291402
  22. Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23:2797-2804. https://doi.org/10.1200/JCO.2005.07.155
  23. Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck 2001;23:547-558. https://doi.org/10.1002/hed.1077
  24. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947. https://doi.org/10.1056/NEJMoa012914
  25. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511. https://doi.org/10.1038/35000501
  26. de Leval L, Bonnet C, Copie-Bergman C, et al. Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Ann Oncol 2012;23:3143-3151. https://doi.org/10.1093/annonc/mds150
  27. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282. https://doi.org/10.1182/blood-2003-05-1545
  28. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Treatment results of tonsillar lymphoma: a 10-year experience. Ann Hematol 2005;84:223-226. https://doi.org/10.1007/s00277-004-0860-0

Cited by

  1. A poor prognostic case of peripheral T-cell lymphoma in the base of tongue with chemotherapy followed by radiation therapy vol.3, pp.1, 2014, https://doi.org/10.1186/2193-1801-3-731
  2. Analysis of treatment outcomes for primary tonsillar lymphoma vol.34, pp.4, 2016, https://doi.org/10.3857/roj.2016.01781
  3. The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective vol.52, pp.1, 2014, https://doi.org/10.5045/br.2017.52.1.3
  4. Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country Pakistan vol.10, pp.1, 2014, https://doi.org/10.4103/jlp.jlp_9_17
  5. Histological studies on the development of porcine tonsils after birth vol.279, pp.8, 2018, https://doi.org/10.1002/jmor.20839
  6. Non-Hodgkin’s lymphoma of the oral cavity and maxillofacial region: a pathologist viewpoint vol.11, pp.9, 2014, https://doi.org/10.1080/17474086.2018.1506326
  7. Frequency and causes of anemia in Lymphoma patients vol.35, pp.1, 2014, https://doi.org/10.12669/pjms.35.1.91